⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2797109 | 1.00 | — | — | |
| SCHEMBL4446554 | 1.00 | — | — | |
| SCHEMBL559639 | 1.00 | — | — | |
| SCHEMBL2797113 | 1.00 | — | — | |
| SCHEMBL4446556 | 1.00 | — | — | |
| Hydrochloric Acid SCHEMBL8123314 | 0.97 | — | — | |
| Bromide SCHEMBL11408199 | 0.97 | — | — | |
| Hydrochloric Acid SCHEMBL30218243 | 0.97 | — | — | |
| Phosphine SCHEMBL27570808 | 0.97 | — | — | |
| SCHEMBL28182951 | 0.97 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024012557-A1 | ANTI-APOPTOTIC BCL-2 FAMILY PROTEIN DEGRADERS, PHARMACEUTICAL COMPOSITIONS, AND THERAPEUTIC APPLICATIONS | BERRYBIO (HONG KONG) LIMITED (CN) | 2024-01-18 | — | — | WO | claimed |
| WO-2024012557-A1 | ANTI-APOPTOTIC BCL-2 FAMILY PROTEIN DEGRADERS, PHARMACEUTICAL COMPOSITIONS, AND THERAPEUTIC APPLICATIONS | BERRYBIO (HONG KONG) LIMITED (CN) | 2024-01-18 | — | — | WO | disclosed |
| CN-115785186-A | Steroid compound and application thereof | 广州润尔眼科生物科技有限公司 | 2023-03-14 | — | — | CN | disclosed |
| CN-109071446-B | Organic reaction in aqueous solution in the presence of hydroxyalkyl (alkyl) cellulose or alkylcellulose | 艾伯维德国有限责任两合公司 | 2022-06-21 | — | — | CN | disclosed |
| EP-1539721-A1 | DIBENZOXAZEPINE | Bayer HealthCare AG (DE) | 2005-06-15 | — | — | EP | disclosed |
| WO-2004033437-A1 | DIBENZOXAZEPINE | BAYER HEALTHCARE AG (DE) | 2004-04-22 | — | — | WO | disclosed |